GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » GlaxoSmithKline Consumer Nigeria PLC (NSA:GLAXOSMITH) » Definitions » Days Payable

GlaxoSmithKline Consumer Nigeria (NSA:GLAXOSMITH) Days Payable : 70.43 (As of Jun. 2023)


View and export this data going back to 2001. Start your Free Trial

What is GlaxoSmithKline Consumer Nigeria Days Payable?

GlaxoSmithKline Consumer Nigeria's average Accounts Payable for the three months ended in Jun. 2023 was ₦1,866 Mil. GlaxoSmithKline Consumer Nigeria's Cost of Goods Sold for the three months ended in Jun. 2023 was ₦2,418 Mil. Hence, GlaxoSmithKline Consumer Nigeria's Days Payable for the three months ended in Jun. 2023 was 70.43.

The historical rank and industry rank for GlaxoSmithKline Consumer Nigeria's Days Payable or its related term are showing as below:

NSA:GLAXOSMITH' s Days Payable Range Over the Past 10 Years
Min: 11.81   Med: 22.11   Max: 166.56
Current: 47.52

During the past 13 years, GlaxoSmithKline Consumer Nigeria's highest Days Payable was 166.56. The lowest was 11.81. And the median was 22.11.

NSA:GLAXOSMITH's Days Payable is not ranked
in the Drug Manufacturers industry.
Industry Median: 88.68 vs NSA:GLAXOSMITH: 47.52

GlaxoSmithKline Consumer Nigeria's Days Payable increased from Mar. 2022 (9.08) to Jun. 2023 (70.43). It may suggest that GlaxoSmithKline Consumer Nigeria delayed paying its suppliers.


GlaxoSmithKline Consumer Nigeria Days Payable Historical Data

The historical data trend for GlaxoSmithKline Consumer Nigeria's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GlaxoSmithKline Consumer Nigeria Days Payable Chart

GlaxoSmithKline Consumer Nigeria Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Days Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 18.31 11.81 166.56 160.24 23.25

GlaxoSmithKline Consumer Nigeria Quarterly Data
Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Jun23
Days Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.08 3.89 14.96 41.41 70.43

Competitive Comparison of GlaxoSmithKline Consumer Nigeria's Days Payable

For the Drug Manufacturers - General subindustry, GlaxoSmithKline Consumer Nigeria's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


GlaxoSmithKline Consumer Nigeria's Days Payable Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, GlaxoSmithKline Consumer Nigeria's Days Payable distribution charts can be found below:

* The bar in red indicates where GlaxoSmithKline Consumer Nigeria's Days Payable falls into.



GlaxoSmithKline Consumer Nigeria Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

GlaxoSmithKline Consumer Nigeria's Days Payable for the fiscal year that ended in Dec. 2022 is calculated as

Days Payable (A: Dec. 2022 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Dec. 2021 ) + Accounts Payable (A: Dec. 2022 )) / count ) / Cost of Goods Sold (A: Dec. 2022 )*Days in Period
=( (706.205 + 1644.639) / 2 ) / 18452.24*365
=1175.422 / 18452.24*365
=23.25

GlaxoSmithKline Consumer Nigeria's Days Payable for the quarter that ended in Jun. 2023 is calculated as:

Days Payable (Q: Jun. 2023 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Dec. 2022 ) + Accounts Payable (Q: Jun. 2023 )) / count ) / Cost of Goods Sold (Q: Jun. 2023 )*Days in Period
=( (1644.639 + 2087.594) / 2 ) / 2417.612*365 / 4
=1866.1165 / 2417.612*365 / 4
=70.43

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


GlaxoSmithKline Consumer Nigeria Days Payable Related Terms

Thank you for viewing the detailed overview of GlaxoSmithKline Consumer Nigeria's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.


GlaxoSmithKline Consumer Nigeria (NSA:GLAXOSMITH) Business Description

Traded in Other Exchanges
N/A
Address
No. 1, Industrial Avenue, Ilupeju, P.M.B. 21218, Ikeja, GSK House, Lagos, NGA
GlaxoSmithKline Consumer Nigeria PLC is a healthcare company that researches, develops, and manufactures pharmaceutical medicines, vaccines, and consumer healthcare products. The company has two reportable segments, the Consumer Healthcare segment consisting of oral care, over-the-counter (OTC) medicines, and nutritional healthcare; and the Pharmaceuticals segment consisting of vaccines and prescription drugs. The company's product line includes panadol, Andrews liver salt, Macleans, ampiclox, Sensodyne, and others. The generates maximum revenue from the Pharmaceuticals segment.

GlaxoSmithKline Consumer Nigeria (NSA:GLAXOSMITH) Headlines

No Headlines